Ofatumumab in refractory anti-muscle-specific tyrosine kinase antibody-positive myasthenia gravis: a case report of successful salvage therapy and mechanistic insights. [PDF]
Front ImmunolZhang Y, Li C, Chen G, Xu H.
europepmc +1 more source
Jiaxin Chen,1,2 Li Feng,1,2 Shiyin Li,2 Haiyan Wang,1,2 Xin Huang,1,2 Cunzhou Shen,1,2 Huiyu Feng1,2 1Department of Neurology and Neurointensive Care Unit, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, People’s Republic of China ...
Feng L +6 more
core +1 more source
Treatment Patterns and Outcomes of Anti-MuSK Antibody-Positive Myasthenia Gravis: A Retrospective Single-Center Study. [PDF]
J Korean Med SciSeo D +4 more
europepmc +1 more source
Prevalence and characteristics of patients with seronegative myasthenia gravis. [PDF]
J NeurolAndersen RK +5 more
europepmc +1 more source
Diagnostic Challenges of LRP4 Antibody Testing in Myasthenia Gravis: A Case Series of Four LRP4 Positive Cases With Uncertain Diagnostic Significance. [PDF]
Case Rep Neurol MedKinnard KR, Khalid E.
europepmc +1 more source
Myasthenia Gravis With Chronic Kidney Disease: A Diagnostic Challenge. [PDF]
Clin Case RepMahmood Z, Mahmud A, Akilimali A.
europepmc +1 more source
Osteoporosis knowledge and health beliefs in ındividuals with myasthenia gravis: a cross-sectional controlled study. [PDF]
Rev Assoc Med Bras (1992)Meral HB +3 more
europepmc +1 more source
Clinical implications of a very late presentation in myasthenia gravis: real world experience in a tertiary center. [PDF]
Arq NeuropsiquiatrFernandes AA +4 more
europepmc +1 more source